Notice of Proposed Sale · 144
Quest Diagnostics Inc.
DGXNYSEEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- QUEST DIAGNOSTICS INC
- Issuer CIK
- 0001022079
- SEC file number
- 001-12215
- Phone
- 9735202700
- Person for whose account securities are to be sold
- Davis J. E.
- Relationships to issuer
- Officer · Director
- Street
- 500 PLAZA DRIVE
- City
- SECAUCUS
- State / country code
- NJ
- Postal code
- 07094
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 10,000 | 2,427,200.00 | 110,373,360 | 09/01/2026 | NYSE | Fidelity Brokerage Services LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Fidelity Brokerage Services LLC
- Street
- 900 Salem Street
- City
- Smithfield
- State / country code
- RI
- Postal code
- 02917
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 02/18/2022 | Restricted Stock Vesting | Issuer | 5,115 | N | 02/18/2022 | Compensation |
| Common | 02/17/2024 | Restricted Stock Vesting | Issuer | 829 | N | 02/17/2024 | Compensation |
| Common | 02/23/2024 | Restricted Stock Vesting | Issuer | 2,598 | N | 02/23/2024 | Compensation |
| Common | 02/24/2024 | Restricted Stock Vesting | Issuer | 1,458 | N | 02/24/2024 | Compensation |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| James E. Davis | Common | 06/01/2026 | 10,000 | 1,941,400.00 |
Seller — prior-sale row 1, entry 1
- Name
- James E. Davis
- Street
- 500 Plaza Drive
- City
- Secaucus
- State / country code
- NJ
- Postal code
- 07094
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 09/01/2026
- Signed
- /s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James E. Davis
- Plan adoption dates
- 08/26/2025
Company context
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We help connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, our insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three adult Americans each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www. QuestDiagnostics.com.
Current securities
Recent company filings
- SCHEDULE 13G - filed by STATE STREET CORP regarding QUEST DIAGNOSTICS INCNov 10, 2026
- 10-Q filingOct 23, 2026
- Other EventsOct 22, 2026
- Results of Operations and Financial ConditionOct 22, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsOct 6, 2026